The Net Margin of OSE Immunotherapeutics SA (OSE.PA) is 44.88%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | 44.88% |
2023-12-31 | -1032.87% |
2022-12-31 | -97.03% |
2021-12-31 | -64.05% |
2020-12-31 | -158.68% |
2019-12-31 | -17.93% |
2018-12-31 | 22.45% |
2017-12-31 | -157.18% |
2016-12-31 | 5395.82% |
2015-12-31 | -139600.00% |